ClearPoint Neuro, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
ClearPoint Neuro, Inc. (CLPT) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $385.60 per share for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2019-11-13
- ClearPoint Neuro, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2019-03-31 was $385.60, a 5915.60% increase year-over-year.
- ClearPoint Neuro, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2018-03-31 was $6.41, a 85.92% decline year-over-year.
- ClearPoint Neuro, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2017-03-31 was $45.53, a 4115.74% increase year-over-year.
- ClearPoint Neuro, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2016-03-31 was $1.08, a 9.09% increase year-over-year.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month |
|---|---|---|---|
| 2019-09-30 | $385.60 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | $385.60 10-Q · filed 2019-08-12 | ||
| 2019-03-31 | $385.60 10-Q · filed 2019-05-13 | ||
| 2018-09-30 | $15.02 10-Q · filed 2018-11-13 | ||
| 2018-06-30 | $6.41 10-Q · filed 2018-08-14 | ||
| 2018-03-31 | $6.41 10-Q · filed 2018-05-15 | ||
| 2017-09-30 | $36.06 10-Q · filed 2017-11-06 | ||
| 2017-06-30 | $35.81 10-Q · filed 2017-08-11 | ||
| 2017-03-31 | $45.53 10-Q · filed 2017-05-09 | ||
| 2016-09-30 | $43.04 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | $43.04 10-Q/A · filed 2016-09-21 | ||
| 2016-03-31 | $1.08 10-Q · filed 2016-05-06 | ||
| 2015-09-30 | $1.50 10-Q · filed 2015-11-13 | ||
| 2015-06-30 | $1.43 10-Q · filed 2015-08-10 | ||
| 2015-03-31 | $0.99 10-Q · filed 2015-05-07 | ||
| 2014-09-30 | $1.88 10-Q · filed 2014-11-14 | ||
| 2014-06-30 | $1.88 10-Q · filed 2014-08-11 | ||
| 2014-03-31 | $7.06 10-Q · filed 2014-05-13 | ||
| 2013-09-30 | $2.18 10-Q · filed 2013-11-13 | ||
| 2013-06-30 | $2.09 10-Q · filed 2013-08-14 | ||
| 2012-09-30 | $2.16 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | $2.16 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |